Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE\OXALIPLATIN Cause Malignant neoplasm progression? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with GEMCITABINE\OXALIPLATIN. This represents 8.8% of all adverse event reports for GEMCITABINE\OXALIPLATIN.

7
Reports of Malignant neoplasm progression with GEMCITABINE\OXALIPLATIN
8.8%
of all GEMCITABINE\OXALIPLATIN reports
1
Deaths
0
Hospitalizations

How Dangerous Is Malignant neoplasm progression From GEMCITABINE\OXALIPLATIN?

Of the 7 reports, 1 (14.3%) resulted in death.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE\OXALIPLATIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE\OXALIPLATIN Cause?

Lymphoma (33) Disease progression (21) Off label use (9) Platelet count decreased (8) Acute kidney injury (7) Diarrhoea (7) Tumour lysis syndrome (6) Vomiting (6) Burkitt's lymphoma (5) Chest discomfort (5)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Related Pages

GEMCITABINE\OXALIPLATIN Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression GEMCITABINE\OXALIPLATIN Demographics